http://www.cdc.gov/ncidod/sars/basics.htm
BASIC INFORMATION ABOUT SARS
April 16, 2003, 12:30 PM ET
A new disease called SARS
The Centers for Disease Control and Prevention (CDC) is investigating a new disease called severe acute respiratory syndrome (SARS) that has recently been reported in Asia, North America, and Europe. As of April 13, about 190 cases of SARS had been reported in the United States. This fact sheet provides basic information about the disease and what is being done to combat its spread.
What are the symptoms and signs of SARS?
The illness usually begins with a fever (measured temperature greater than 100.4癋 [>38.0癈]). The fever is sometimes associated with chills or other symptoms, including headache, general feeling of discomfort and body aches. Some people also experience mild respiratory symptoms at the outset.
After 2 to 7 days, SARS patients may develop a dry, nonproductive cough that might be accompanied by or progress to the point where insufficient oxygen is getting to the blood. In 10 percent to 20 percent of cases, patients will require mechanical ventilation. For more information, see the MMWR dispatch.
How SARS spreads
The primary way that SARS appears to spread is by close person-to-person contact. Most cases of SARS have involved people who cared for or lived with someone with SARS, or had direct contact with infectious material (for example, respiratory secretions) from a person who has SARS. Potential ways in which SARS can be spread include touching the skin of other people or objects that are contaminated with infectious droplets and then touching your eye(s), nose, or mouth. This can happen when someone who is sick with SARS coughs or sneezes droplets onto themselves, other people, or nearby surfaces. It also is possible that SARS can be spread more broadly through the air or by other ways that are currently not known.
How long is a person with SARS infectious to others?
Information to date suggests that people are most likely to be infectious when they have symptoms, such as fever or cough. However, it is not known how long before or after their symptoms begin that patients with SARS might be able to transmit the disease to others.
Who is at risk for SARS
Cases of SARS continue to be reported mainly among people who have had direct close contact with an infected person, such as those sharing a household with a SARS patient and health-care workers who did not use infection control procedures while taking care of a SARS patient. In the United States, there is no indication of community spread at this time. The Centers for Disease Control and Prevention (CDC) continues to monitor this situation very closely.
Is there a test for SARS?
No "test" is available yet for SARS. However, the Centers for Disease Control and Prevention (CDC), in collaboration with World Health Organization (WHO) and other laboratories, has developed 2 research tests that appear to be very promising in detecting antibodies to the new coronavirus. The Centers for Disease Control and Prevention (CDC) is working to refine and share this testing capability as soon as possible with laboratories across the United States and internationally.
What medical treatment is recommended for patients with SARS?
The Centers for Disease Control and Prevention (CDC) currently recommends that patients with SARS receive the same treatment that would be used for any patient with serious community-acquired atypical pneumonia of unknown cause.
Is there any reason to think SARS is or is not related to terrorism?
Information currently available about SARS indicates that people who appear to be most at risk are either health-care workers taking care of sick people or family members or household contacts of those who are infected with SARS. That pattern of transmission is what would typically be expected in a contagious respiratory or flu-like illness.
Travel and Quarantine
What should I do if I have recently traveled to a country where cases of SARS have been reported?
You should monitor your own health for 10 days following your return. If you become ill with a fever of more than 100.4°F [ >38.0 ° C] that is accompanied by a cough or difficulty breathing or that progresses to a cough and/or difficulty breathing, you should consult a health-care provider. To help your health-care provider make a diagnosis, tell him or her about any recent travel to regions where cases of SARS have been reported and whether you were in contact with someone who had these symptoms.
THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) RECOMMENDATIONS
The Centers for Disease Control and Prevention (CDC) has issued recommendations and guidelines for people who may be affected by this outbreak.
For individuals considering travel to affected parts of Asia:
The Centers for Disease Control and Prevention (CDC) advises that people planning elective or nonessential travel to mainland China and Hong Kong, Singapore, and Hanoi, Vietnam may wish to postpone their trips until further notice.
For individuals who think they might have SARS:
People with symptoms of SARS (fever greater than 100.4°F [ >38.0 ° C] accompanied by a cough and/or difficulty breathing) should consult a health-care provider. To help the health-care provider make a diagnosis, tell them about any recent travel to places where SARS has been reported or whether there was contact with someone who had these symptoms
WHAT THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) IS DOING ABOUT SARS
The Centers for Disease Control and Prevention (CDC) is working closely with the World Health Organization (WHO) and other partners in a global effort to address the SARS outbreak. For its part, CDC has taken the following actions:
(1) Activated its Emergency Operations Center to provide round-the-clock coordination and response.
(2) Committed more than 300 medical experts and support staff to work on the SARS response.
(3) Deployed medical officers, epidemiologists, and other specialists to assist with on-site investigations around the world.
(4) Provided ongoing assistance to state and local health departments in investigating possible cases of SARS in the United States.
(5) Conducted extensive laboratory testing of clinical specimens from SARS patients to identify the cause of the disease.
(6) Initiated a system for distributing health alert notices to travelers who may have been exposed to cases of SARS.
____________________________________________________________
Isolation and Quarantine
April 3, 2003, 6:30 PM EST
To contain the spread of a contagious illness, public health authorities rely on many strategies. Two of these strategies are isolation and quarantine. Both are common practices in public health and both aim to control exposure to infected or potentially infected individuals. Both may be undertaken voluntarily or compelled by public health authorities. The two strategies differ in that isolation applies to people who are known to have an illness and quarantine applies to those who have been exposed to an illness but who may or may not become infected.
Isolation: For People Who Are Ill
Isolation of people who have a specific illness separates them from healthy people and restricts their movement to stop the spread of that illness. Isolation allows for the focused delivery of specialized health care to people who are ill, and it protects healthy people from getting sick. People in isolation may be cared for in their homes, in hospitals, or at designated health care facilities. Isolation is a standard procedure used in hospitals today for patients with tuberculosis (TB) and certain other infectious diseases. In most cases, isolation is voluntary; however, many levels of government (federal, state, and local) have basic authority to compel isolation of sick people to protect the public.
Quarantine: For People Who Have Been Exposed But Are Not Ill
Quarantine, in contrast, applies to people who have been exposed and may be infected but are not yet ill. Separating exposed people and restricting their movements is intended to stop the spread of that illness. Quarantine is medically very effective in protecting the public from disease.
States generally have authority to declare and enforce quarantine within their borders. This authority varies widely from state to state, depending on the laws of each state. The Centers for Disease Control and Prevention (CDC), through its Division of Global Migration and Quarantine, also is empowered to detain, medically examine, or conditionally release individuals suspected of carrying certain communicable diseases. This authority derives from section 361 of the Public Health Service Act (42 U.S.C. 264), as amended.
SARS and Isolation
SARS patients in the United States are being isolated until they are no longer infectious. This practice allows patients to receive appropriate care, and it contains the potential spread of the illness. Those who are more severely ill are being cared for in hospitals. Those whose illness is mild are being cared for at home. Individuals being cared for at home have been asked to avoid contact with other people and to remain at home until 10 days after their symptoms have resolved.
____________________________________________________________
Interim Guidance on Infection Control Precautions for Patients with Suspected Severe Acute Respiratory Syndrome (SARS) and Close Contacts in Households
Patients with SARS pose a risk of transmission to close household contacts and health care personnel in close contact. The duration of time before or after onset of symptoms during which a patient with SARS can transmit the disease to others is unknown. The following infection control measures are recommended for patients with suspected SARS in households or residential settings. These recommendations are based on the experience in the United States to date and may be revised as more information becomes available.
(1) SARS patients should limit interactions outside the home and should not go to work, school, out-of-home child care, or other public areas until 10 days after the resolution of fever, provided respiratory symptoms are absent or improving. During this time, infection control precautions should be used, as described below, to minimize the potential for transmission.
(2) All members of a household with a SARS patient should carefully follow recommendations for hand hygiene (e.g., frequent hand washing or use of alcohol-based hand rubs), particularly after contact with body fluids (e.g., respiratory secretions, urine, or feces).
(3) Use of disposable gloves should be considered for any direct contact with body fluids of a SARS patient. However, gloves are not intended to replace proper hand hygiene. Immediately after activities involving contact with body fluids, gloves should be removed and discarded and hands should be cleaned. Gloves must never be washed or reused.
(4) Each patient with SARS should be advised to cover his or her mouth and nose with a facial tissue when coughing or sneezing. If possible, a SARS patient should wear a surgical mask during close contact with uninfected persons to prevent spread of infectious droplets. When a SARS patient is unable to wear a surgical mask, household members should wear surgical masks when in close contact with the patient.
(5) Sharing of eating utensils, towels, and bedding between SARS patients and others should be avoided, although such items can be used by others after routine cleaning (e.g., washing with soap and hot water). Environmental surfaces soiled by body fluids should be cleaned with a household disinfectant according to manufacturer's instructions; gloves should be worn during this activity.
(6) Household waste soiled with body fluids of SARS patients, including facial tissues and surgical masks, may be discarded as normal waste.
(7) Household members and other close contacts of SARS patients should be actively monitored by the local health department for illness.
(8) Household members or other close contacts of SARS patients should be vigilant for the development of fever or respiratory symptoms and, if these develop, should seek healthcare evaluation. In advance of evaluation, healthcare providers should be informed that the individual is a close contact of a SARS patient. Household members or other close contacts with symptoms of SARS should follow the same precautions recommended for SARS patients.
(9) At this time, in the absence of fever or respiratory symptoms, household members or other close contacts of SARS patients need not limit their activities outside the home.
____________________________________________________________
FREQUENTLY ASKED QUESTIONS
April 16, 2003, 12:00 PM ET
Is the use of ribavirin (or other antiviral drugs) effective in the treatment of patients with SARS?
At present, the most efficacious treatment regimen, if any, is unknown. In several locations, therapy has included antivirals such as oseltamivir or ribavirin. Steroids also have been given orally or intravenously to patients in combination with ribavirin and other antimicrobials. In the absence of controlled clinical trials, however, the efficacy of these regimens remains unknown. Early information from laboratory experiments suggests that ribavirin does not inhibit virus growth or cell-to-cell spread of one isolate of the new coronavirus that was tested. Additional laboratory testing of ribavirin and other antiviral drugs is being done to see if an effective treatment can be found.
Cause of SARS
What is the cause of SARS?
Scientists at the Centers for Disease Control and Prevention (CDC) and other laboratories have detected a previously unrecognized coronavirus in patients with SARS. This new coronavirus is the leading hypothesis for the cause of SARS, however, other viruses are still under investigation as potential causes.
What are coronaviruses?
Coronaviruses are a group of viruses that have a halo or crown-like (corona) appearance when viewed under a microscope. These viruses are a common cause of mild to moderate upper-respiratory illness in humans and are associated with respiratory, gastrointestinal, liver and neurologic disease in animals. Coronaviruses can survive in the environment for as long as three hours.
What evidence is there to suggest that coronaviruses may be linked with SARS?
The Centers for Disease Control and Prevention (CDC) scientists isolated a virus from the tissues of two SARS patients and then used several laboratory methods to characterize it. Examination by electron microscopy revealed that the virus has the distinctive shape and appearance of coronaviruses, and genetic analysis suggests that this new virus does belong to the family of coronaviruses but differs from previously identified family members. Tests of serum specimens from people with SARS showed that they appeared to have been recently infected with this virus. Other tests demonstrated that this previously unrecognized coronavirus was present in a variety of clinical specimens (including specimens obtained by nose and throat swab) from other SARS patients with direct or indirect links to the outbreak. These results and other findings reported from laboratories participating in the World Health Organization (WHO) network provide growing evidence in support of the hypothesis that this new coronavirus is the cause of SARS. Additional studies of the link between this coronavirus and SARS are under way.
If coronaviruses usually cause mild illness in humans, how could this new coronavirus be responsible for a potentially life-threatening disease such as SARS?
There is not enough information about the new virus to determine the full range of illness that it might cause. Coronaviruses have occasionally been linked to pneumonia in humans, especially people with weakened immune systems. The viruses also can cause severe disease in animals, including cats, dogs, pigs, mice, and birds.
Has new information about coronavirus changed the recommendations for medical treatment for patients with SARS?
The possibility that coronavirus is the cause of SARS has not changed treatment recommendations. The new coronavirus is being tested against various antiviral drugs to see if an effective treatment can be found.
What about reports from other laboratories suggesting that the cause of SARS may be a paramyxovirus?
Researchers from several laboratories participating in the WHO network have reported the identification of a paramyxovirus in clinical specimens from SARS patients. These laboratories are still investigating the possibility that a paramyxovirus is a cause of SARS.
The Outbreak
What is the Centers for Disease Control and Prevention (CDC) doing to combat this health threat?
The Centers for Disease Control and Prevention (CDC) is working closely with WHO and other partners as part of a global collaboration to address the SARS outbreak. For its part in this international effort, CDC has taken the following actions:
(1) Activated its Emergency Operations Center to provide round-the-clock coordination and response.
(2) Committed more than 300 infectious disease experts and support staff to work on the SARS response.
(3) Deployed medical officers, epidemiologists, and other specialists to assist with on-site investigations around the world.
(4) Provided ongoing assistance to state and local health departments in investigating possible cases of SARS in the United States.
(5) Issued multiple notices providing guidance on ways to minimize the risk for SARS in health-care facilities, in the household, when traveling, and in other settings.
(6) Conducted extensive laboratory testing of clinical specimens from SARS patients to identify the cause of the disease.
(7) Initiated a system for distributing health alert notices to travelers who may have been exposed to cases of SARS.
As always, the Centers for Disease Control and Prevention (CDC) is committed to communicating regularly and effectively with public health professionals, elected leaders, clinicians, and the general public.
Travel and Quarantine
What are CDC's quarantine officials doing to prevent and control the spread of SARS?
CDC's quarantine inspectors or their designees are distributing health alert cards to air passengers returning in airplanes either directly or indirectly to the United States from China, Singapore, and Vietnam. The notices inform travelers about SARS and its symptoms and asks them to monitor their health for 10 days and to see a doctor if they get a fever with a cough or have difficulty breathing. The Centers for Disease Control and Prevention (CDC) distributes approximately 18,000 health alert notices each day to air travelers returning from the affected regions at 23 ports of entry. Inspectors also are boarding airplanes if a traveler has been reported with symptoms matching the case definition of SARS.
WHO has recommended procedures for pre-departure screening of airline passengers from some countries for respiratory illnesses or other symptoms of SARS.
What information about SARS is being provided to people traveling on ships?
SARS information contained on CDC's health alert cards is being provided by the major shipping associations and the International Council of Cruise Lines to people traveling on cargo ships and cruise ships at U.S. ports. Inspectors also are boarding ships if a passenger or crew member has been reported with symptoms matching the case definition of SARS.
What does a quarantine inspector do?
Quarantine inspectors serve as important guardians of health at borders and ports of entry into the United States. They routinely respond to illness in arriving passengers and ensure that the appropriate medical action is taken.
What is considered routine health inspections of airplanes or ships versus what is happening now?
Routine health inspections consist of working with airline, cargo ship, and cruise ship companies to protect passengers and crew from certain infectious diseases. Quarantine inspectors meet arriving aircraft and ships reporting ill passengers and/or crew (as defined in the foreign quarantine regulations [pdf]) and assist them in getting appropriate medical treatment.
What is the risk to individuals who may have shared a plane or boat trip with a suspected SARS patient?
Cases of SARS continue to be reported primarily among people who have had direct close contact with an infected person, such as those sharing a household with a SARS patient and health-care workers who did not use infection control procedures while attending to a SARS patient. SARS also has occurred among air travelers, primarily travelers to and from Hong Kong, Hanoi, Singapore, and mainland China.
The Centers for Disease Control and Prevention (CDC) is requesting locating information from travelers who are on flights with people suspected of having SARS. CDC, with the help of state and local health authorities, is attempting to follow-up with these travelers for 14 days to make sure no one develops symptoms consistent with SARS.
Who actually notifies quarantine officials of potential SARS cases? Is it the crew of the airplane or ship? The passengers?
Under foreign quarantine regulations, the master of a ship or captain of an airplane coming into the United States from a foreign port is required by law to report certain illnesses among passengers. The illness must be reported to the nearest quarantine official. If possible, the crew of the airplane or ship will try to relocate the ill passenger or crew member away from others. If the passenger is only passing through a port of entry on his/her way to another destination, port health authorities may refer the passenger to a local health authority for assessment and care.
If I'm on board an airplane or ship with someone suspected of having SARS, will I be allowed to continue to my destination?
The Centers for Disease Control and Prevention (CDC) does not currently recommend that the onward travel of healthy passengers be restricted in the event that a passenger or crew member suspected of having SARS is removed from the ship or airplane by port health authorities. All passengers and crew members may be advised by port health authorities to seek medical attention if they develop SARS symptoms.
What does a quarantine official do if a passenger is identified as meeting the case definition for suspected SARS?
Quarantine officials arrange for appropriate medical assistance to be available when the airplane lands or the ship docks, including medical isolation. Isolation is important not only for the sick passenger's comfort and care but also for the protection of members of the public. Isolation is recommended for travelers with suspected cases of SARS until appropriate medical treatment can be provided or until they are no longer infectious.
What does a quarantine official do if a passenger identified as meeting the case definition for suspected SARS refuses to be isolated?
Many levels of government (Federal, State, and local) have basic authority to compel isolation of sick persons to protect the public. In the event that it is necessary to compel isolation of a sick passenger, the Centers for Disease Control and Prevention (CDC) will work with appropriate State and local officials to ensure that the passenger does not infect others.
____________________________________________________________
Interim Guidance: Air Medical Transport for Severe Acute Respiratory Syndrome (SARS) Patients
March 26, 2003, 6:30 PM EST
Introduction
The current outbreak of Severe Acute Respiratory Syndrome (SARS) has included reports of cases in southeast Asia, North America and Europe, and required urgent air evacuation of patients with severe illness. This guidance is intended to assist air medical transport (AMT) service providers using specialized aircraft to transport SARS patients while ensuring the safety of patients and transport personnel. It should not be generalized to commercial passenger aircraft. These interim recommendations are based on standard infection control practices, AMT standards, and epidemiologic information from ongoing investigations of SARS, including experience from transport of two patients during this outbreak.
Currently recommended infection control measures for hospital patients with SARS include Standard Precautions (with eye protection to prevent droplet exposure), plus Contact and Airborne Precautions. Respiratory protection using respirators providing at least 95% filtering efficiency (e.g., N--95) with appropriate fit-testing is recommended.
I. Air Transport of SARS Patients, General Considerations
SARS patients should be transported on a dedicated AMT mission minimizing crew size. There should not be any patients or passengers who do not have SARS on board.
If possible, a single caregiver should be assigned to the SARS patient.
All SARS patient movement involving U.S. citizens should be coordinated with appropriate state and federal health authorities, including the Centers for Disease Control and Prevention (CDC) (24 hour response number: (770) 488-7100) and the Department of State, before movement begins. International movement of SARS patients may require special approvals by countries that will be over-flown, aircraft servicing locations, patient rest stop hospitals, and/or final destinations.
II. Airframe Selection and Cabin Airflow
AMT service providers should consult manufacturer(s) of their aircraft to identify cabin airflow characteristics, including: HEPA filtration and directional airflow capabilities, air outlet location, presence or absence of air mixing between cockpit and patient-care cabin during flight, and the time and aircraft configuration required to perform a post-mission airing-out of the aircraft.
Aircraft with forward-to-aft cabin airflow and a separate cockpit cabin are recommended for transport of SARS patients. The flight deck/cockpit crew in aircraft with forward-to-aft cabin airflow and separate patient-care compartment are not required to wear respirators unless they enter the patient-care compartment.
Aft-to-forward cabin airflow may create a significant risk of airborne transmission to both cabin and flight deck personnel. If an aircraft with aft-to-forward airflow must be used, all personnel on board must wear fit-tested N-95 respirators throughout the flight.
Aircraft that re-circulate cabin and flight deck air without HEPA filtration should not be selected for SARS patient transport.
Aircraft ventilation should remain on at all times during transport of SARS patients, including during ground delays.
Aircraft that provide separate upwind cabin space for crew members to perform necessary personal activities (eating, drinking, handling contact lenses, etc.) should be selected for flights likely to exceed 4 hours.
III. Patient Placement
The in-flight environment may preclude the creation of a true negative pressure room; however, some aircraft designs permit a downwind zone of relative airflow isolation. The airflow of each aircraft should form the basis for litter and seat assignments. In general:
SARS patients should be positioned as far downwind with regard to cabin airflow as possible.
If the AMT aircraft uses vertical litter tiers, SARS litter patients should be placed in the lowest position in the tier.
Ambulatory SARS patients should be seated next to the cabin sidewall.
If a non-SARS patient must be transported simultaneously with SARS patient(s), the non-SARS patient must wear an N-95 respirator during transport and should not be positioned downwind from, or within 3 feet of, the SARS patient.
If several SARS patients are transported, they may be moved as a group (cohorted) in an aircraft that provides appropriate airflow and filtration characteristics as described above.
IV. Infection Control
General:
Personnel should not wear leather or other "flight" gloves while providing patient care.
Eating, drinking, application of cosmetics, and handling of contact lenses should not be done in the immediate patient care area.
Handling or storage of medication or clinical specimens should not be done in areas where food or beverages are stored or prepared.
Protective equipment and procedures:
Disposable, non-sterile gloves must be worn for all patient contact.
Gloves are removed and discarded in designated trash bags after patient care is completed (e.g., between patients) or when soiled or damaged.
Hands must be washed or disinfected with waterless hand sanitizer after removal of gloves.
Disposable fluid-resistant gowns should be worn for all patient care activity.
Gowns are removed and discarded in designated trash bags after patient care is completed or when soiled or damaged.
Goggles or face-shields must be worn for all patient care within 6 feet of the patient. Corrective eyeglasses alone are not appropriate protection.
Fit-tested N-95 respirators are approved for in-flight use and should be worn by personnel in the patient-care cabin at all times.
Fit-tested N-95 respirators should be worn by cockpit/flight-deck crew if an aircraft cannot provide forward-to-aft airflow.
For cockpit crews, aircraft aviator tight-fitting face-pieces capable of delivering oxygen that has not mixed with cabin air may be used in lieu of a disposable N-95 respirator.
Respirators may not be removed to eat or drink. Personal activities that require removal of respirators should not be performed in the patient-care cabin.
The patient may wear a paper surgical mask to reduce droplet production, if tolerated.
Oxygen delivery with simple and non-rebreather facemasks may be used for patient oxygen support during flight.
Cardiopulmonary resuscitation (CPR) should only be performed using a resuscitation bag-valve mask equipped with HEPA filtration of expired air.
V. Mechanically Ventilated Patients
Mechanical ventilators for SARS patients must provide HEPA filtration of airflow exhaust.
AMT services should consult their ventilator equipment manufacturer to confirm appropriate filtration capability and the effect of filtration on positive pressure ventilation.
VI. Clinical Specimens
Standard precautions must be used when collecting and transporting clinical specimens.
Specimens should be stored only in designated coolers or refrigerators.
Clinical specimens should be labeled with appropriate patient information and placed in a clean zip-lock bag for storage and transport.
VII. Waste Disposal
Dry solid waste, e.g., used gloves, dressings, etc., should be collected in biohazard bags for disposal as regulated medical waste in accordance with local requirements at the destination medical facility.
Waste that is saturated with blood or body fluids should be collected in leak-proof biohazard bags or containers for disposal as regulated medical waste in accordance with local requirements at the destination medical facility.
Sharp items such as used needles or scalpel blades should be collected in puncture resistant sharps containers for disposal as regulated medical waste in accordance with local requirements at the destination medical facility.
Suctioned fluids and secretions should be stored in sealed containers for disposal as regulated medical waste in accordance with local requirements at the destination medical facility. Handling that might create splashes or aerosols during flight should be avoided.
Suction device exhaust should not be vented into the cabin without HEPA filtration. Portable suction devices should be fitted with in-line HEPA filters. Externally vented suction should not be used during ground operation.
Excretions (feces, urine) may be carefully poured down the aircraft toilet.
VIII. Cleaning and Disinfection
After transporting a SARS patient, all exits and doors should be opened and the interior of the aircraft should be aired out with the aircraft air conditioning running at maximum capacity for a specified time based on aircraft-specific engineering features. Personnel boarding the aircraft must wear N-95 respirators until this "airing out" is complete.
Cleaning should be postponed until airing out is complete.
Compressed air that might re-aerosolize infectious material should not be used for cleaning the aircraft.
Non-patient-care areas of the aircraft should be cleaned and maintained according to manufacturer's recommendations.
Cleaning personnel should wear non-sterile gloves, disposable gowns and face shields while cleaning patient-care areas.
Patient-care areas (including stretchers, railings, medical equipment control panels, and adjacent flooring, walls and work surfaces likely to be directly contaminated during care) should be cleaned using an EPA-registered hospital disinfectant in accordance with aircraft manufacturer's recommendations.
Spills of body fluids during transport should be cleaned by placing absorbent material over the spill and collecting the used cleaning material in a biohazard bag. The area of the spill should be cleaned using an EPA-registered hospital disinfectant. Ground service personnel should be notified of the spill location and initial clean-up performed.
Contaminated web seats or seat cushions should be placed in a biohazard bag and labeled with the location and type of contamination for later disposal or cleaning.
Contaminated reusable patient care equipment should be placed in biohazard bags and labeled for cleaning and disinfection at the AMT service medical equipment section.
Personnel should wear non-sterile gloves, disposable gowns and face shields while cleaning reusable equipment.
Reusable equipment should be cleaned and disinfected according to manufacturer's instructions.
IX. Logistical Planning and Post-Mission Follow-Up
Sufficient infection control supplies should be on board to support the expected duration of the mission plus additional time should the aircraft experience maintenance delays or weather diversions.
Flight planning should identify emergency or unexpected diversion airfields, and coordinate with authorities in advance.
Upon mission termination, the AMT team should provide the following information to their medical director: mission number/date; address of the team/aircraft basing; duration of patient transport; names, contact information, and crew positions (including estimated duration of direct patient care provided) of mission personnel.
AMT services should designate individuals responsible for performing post-mission monitoring of mission personnel and reporting results to the AMT service medical director.
Mission personnel should be monitored (directly or by telephone) twice daily for 10 days for evidence of fever or respiratory illness.
X. Ground/In-Flight Emergency Procedures
AMT service providers should have a written plan addressing patient handling during in-flight and/or ground emergency situations. Activities such as donning life vests and litter-patient emergency egress may create special exposure risks. Use of N-95 respirators must be weighed against time constraints and on-board emergency conditions (e.g., smoke in the cabin, sudden cabin decompression). Gowns and latex gloves represent a fire/flash hazard and should not be worn during ground or in-flight emergency response situations.
Acknowledgements
This guidance was prepared in cooperation with and with contributions from:
United States Department of Defense
US Transportation Command (USTRANSCOM)
Headquarters Air Mobility Command (HQ AMC)
US Pacific Command (USPACOM)
Headquarters Pacific Air Forces (HQ PACAF)
US Army Medical Research Institute of Infectious Diseases (USAMRIID)
United States Department of State
Commission on Accreditation of Air Medical Transport Services (CAMTS)
Aerospace Medicine Association (AsMA) |